DEA Bans Bromazolam: The Latest Sketchy Substance Gets Scheduled
Published Date: 3/16/2026
Rule
Summary
Starting March 16, 2026, bromazolam—a drug that can be dangerous—is temporarily placed in Schedule I, the strictest drug category. This means anyone making, selling, or using bromazolam will face tough rules and penalties until March 16, 2028. The goal? To keep the public safe from harm while the government watches closely.
Analyzed Economic Effects
5 provisions identified: 0 benefits, 5 costs, 0 mixed.
Bromazolam placed in Schedule I
If you make, sell, possess, or use bromazolam, it is temporarily placed in Schedule I of the Controlled Substances Act from March 16, 2026 through March 16, 2028 (with a possible one-year extension). That means handling bromazolam without authorization may lead to criminal, civil, or administrative penalties under Schedule I rules.
DEA registration and compliance required
If you handle bromazolam (manufacture, distribute, import, export, research, chemical analysis, or possess), you must be registered with the DEA as of March 16, 2026 and follow Schedule I security, labeling, inventory, recordkeeping, reporting, and order-form rules. Current DEA registrants have 30 calendar days from March 16, 2026 to comply with labeling, inventory, and recordkeeping requirements.
Manufacture limited to DEA-registered firms
Only DEA-registered manufacturers may manufacture bromazolam under an assigned manufacturing quota as of March 16, 2026. Manufacturing without DEA registration or outside assigned quota is unlawful and may lead to sanctions.
Surrender stocks if not registered
If you do not want or cannot obtain a Schedule I registration to handle bromazolam, you must surrender all quantities you currently hold as of March 16, 2026. Possession or handling after that date without authorization is unlawful and may lead to prosecution.
Research continuation and 90-day rule
If you are conducting research on bromazolam and are already registered to research another Schedule I substance on March 16, 2026, you may continue that bromazolam research if you submit a completed application to register or modify your registration within 90 calendar days after March 16, 2026. If DEA issues an order to show cause, you may not continue research; expedited hearings must be held not later than 45 calendar days after a hearing request.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-16665, Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through June 30, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
2026-16413, Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing O-DSMT in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle O-DSMT.
2026-16375, Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1- yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone) from schedule IV to schedule V of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule V controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle suvorexant, lemborexant, and daridorexant.
2026-15624, Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as list I chemicals under the CSA. The current listing of 3,4- MDP-2-P methyl glycidic acid includes its salts, optical and geometric isomers, and salts of isomers. DEA proposes the new listing to read as follows: 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its esters, not listed elsewhere in the CSA, its optical and geometric isomers, its salts, salts of its optical and geometric isomers, salts of its esters, not listed elsewhere in the CSA, and any combination thereof, whenever the existence of such is possible.
Previous / Next Documents
Previous: 2026-04990, Revocation of the 30-Day Notification Requirement Prior to Termination of Lease for Nonpayment of Rent; Indefinite Delay of Effective Date
HUD is hitting the pause button on a new rule that would have stopped the 30-day heads-up before evicting tenants for not paying rent. This means public housing tenants and property owners won’t see changes just yet, as HUD reviews feedback and legal challenges. No rent-related notices are changing for now, so everyone can breathe easy until HUD decides the next move.
Next: 2026-05073, Fisheries of the Northeastern United States; Scup Fishery; 2026 Scup Winter I Commercial Quota Harvested
The 2026 Winter I commercial quota for scup fish has been fully caught, so commercial fishing boats can’t land scup until April 30, 2026. This affects all federally permitted scup fishers in the Northeastern U.S., who must stop landing scup immediately to protect the fish population. The closure helps keep the fishery healthy and fair for everyone involved.